AAAAAA

   
Results: 1-12 |
Results: 12

Authors: RAJMAN I HARPER L MCPAKE D KENDALL MJ WHEELER DC
Citation: I. Rajman et al., LOW-DENSITY-LIPOPROTEIN SUBFRACTION PROFILES IN CHRONIC-RENAL-FAILURE, Nephrology, dialysis, transplantation, 13(9), 1998, pp. 2281-2287

Authors: RAJMAN I LORCH U HEMINGWAY J TAUBEL J
Citation: I. Rajman et al., PLASMA HISTAMINE CONCENTRATIONS IN RELATION TO INFUSIONS CONTAINING POLYSORBATE-80 AS A VEHICLE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 6-6

Authors: RAJMAN I WISE S HEMINGWAY J AMIN D MANT T
Citation: I. Rajman et al., MODIFIED CARBON-DIOXIDE INHALATION TEST AS A MODEL FOR ANXIETY CHALLENGE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 53-53

Authors: RAJMAN I LIP GYH CRAMB R MAXWELL SRJ ZARIFIS J BEEVERS DG KENDALL MJ
Citation: I. Rajman et al., ADVERSE CHANGE IN LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS PROFILE WITH ESTROGEN-ONLY HORMONE REPLACEMENT THERAPY, Quarterly Journal of Medicine, 89(10), 1996, pp. 771-778

Authors: RAJMAN I KENDALL MJ WHEELER DC
Citation: I. Rajman et al., ABNORMAL LDL SUBFRACTION PROFILES IN RENAL-TRANSPLANT RECIPIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3457-3457

Authors: RAJMAN I KENDALL MJ CRAMB R HOLDER RL SALIH M GAMMAGE MD
Citation: I. Rajman et al., INVESTIGATION OF LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS AS A CORONARY RISK FACTOR IN NORMOTRIGLYCERIDAEMIC MEN, Atherosclerosis, 125(2), 1996, pp. 231-242

Authors: RAJMAN I HARPER L KENDALL MJ WHEELER DC
Citation: I. Rajman et al., ATHEROGENIC LOW-DENSITY-LIPOPROTEIN (LDL) SUBFRACTION PROFILES IN DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 558-558

Authors: RAJMAN I MAXWELL S CRAMB R KENDALL M
Citation: I. Rajman et al., PARTICLE-SIZE - THE KEY TO THE ATHEROGENIC LIPOPROTEIN, Quarterly Journal of Medicine, 87(12), 1994, pp. 709-720

Authors: RAJMAN I KENDALL M CRAMB R
Citation: I. Rajman et al., THE OXIDATION HYPOTHESIS OF ATHEROSCLEROSIS, Lancet, 344(8933), 1994, pp. 1363-1364

Authors: KENDALL MJ RAJMAN I
Citation: Mj. Kendall et I. Rajman, A RISK-BENEFIT ASSESSMENT OF CELIPROLOL IN THE TREATMENT OF CARDIOVASCULAR-DISEASE, Drug safety, 10(3), 1994, pp. 220-232

Authors: KENDALL MJ RAJMAN I MAXWELL SRJ
Citation: Mj. Kendall et al., CARDIOPROTECTIVE THERAPEUTICS - DRUGS USED IN HYPERTENSION, HYPERLIPEMIA, THROMBOEMBOLISM, ARRHYTHMIAS, THE POSTMENOPAUSAL STATE AND AS ANTIOXIDANTS, Postgraduate medical journal, 70(823), 1994, pp. 329-343

Authors: RAJMAN I KENDALL MJ
Citation: I. Rajman et Mj. Kendall, SUDDEN CARDIAC DEATH AND THE POTENTIAL ROLE OF BETA-ADRENOCEPTOR-BLOCKING DRUGS, Postgraduate medical journal, 69(818), 1993, pp. 903-911
Risultati: 1-12 |